23,289 Shares in CVS Health Corporation (NYSE:CVS) Purchased by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. purchased a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 23,289 shares of the pharmacy operator's stock, valued at approximately $1,578,000.

A number of other large investors also recently bought and sold shares of the business. Whitebox Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter valued at about $249,000. Jennison Associates LLC boosted its holdings in CVS Health by 503.8% in the 1st quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator's stock valued at $128,477,000 after purchasing an additional 1,582,257 shares during the last quarter. Cerity Partners LLC grew its stake in shares of CVS Health by 25.0% in the 1st quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator's stock valued at $43,920,000 after buying an additional 129,535 shares during the period. Bank of New York Mellon Corp raised its position in shares of CVS Health by 2.1% during the 1st quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator's stock valued at $608,481,000 after buying an additional 183,813 shares during the period. Finally, Fairfax Financial Holdings Ltd. Can acquired a new position in CVS Health in the fourth quarter valued at approximately $121,742,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.22% of the company's stock.

CVS Health Stock Down 4.9%

Shares of NYSE:CVS traded down $3.03 during midday trading on Thursday, reaching $58.82. The company had a trading volume of 12,429,501 shares, compared to its average volume of 10,014,127. The stock has a market capitalization of $74.41 billion, a P/E ratio of 14.04, a PEG ratio of 0.87 and a beta of 0.57. The stock's fifty day moving average price is $64.68 and its 200-day moving average price is $63.22. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the business posted $1.31 EPS. CVS Health's quarterly revenue was up 7.0% compared to the same quarter last year. Equities research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.52%. CVS Health's payout ratio is currently 63.48%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Mizuho upped their price target on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Truist Financial boosted their price target on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $74.82.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.